Mathieu Larroquette

901 total citations
12 papers, 239 citations indexed

About

Mathieu Larroquette is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mathieu Larroquette has authored 12 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Surgery. Recurrent topics in Mathieu Larroquette's work include Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mathieu Larroquette is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mathieu Larroquette collaborates with scholars based in France. Mathieu Larroquette's co-authors include Charlotte Domblides, Marine Gross‐Goupil, Alain Ravaud, Amaury Daste, Benjamin Besse, Jean‐Christophe Bernhard, François Le Loarer, Fabrice Barlési, Jean‐Charles Soria and Christophe Rey and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Cancer Treatment Reviews.

In The Last Decade

Mathieu Larroquette

10 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Larroquette France 6 131 95 95 90 45 12 239
Avi Spira United States 3 121 0.9× 72 0.8× 76 0.8× 63 0.7× 59 1.3× 7 202
Marco Moreira France 7 132 1.0× 96 1.0× 50 0.5× 105 1.2× 31 0.7× 10 208
Giulio Mandelli Italy 5 68 0.5× 109 1.1× 81 0.9× 62 0.7× 70 1.6× 6 225
Maxime Brunet France 5 136 1.0× 70 0.7× 113 1.2× 47 0.5× 29 0.6× 11 226
Robert A. Belderbos Netherlands 7 136 1.0× 39 0.4× 68 0.7× 156 1.7× 52 1.2× 14 283
Jiamin Chen United States 3 132 1.0× 150 1.6× 115 1.2× 57 0.6× 94 2.1× 3 278
Emeline Vinatier France 7 155 1.2× 51 0.5× 132 1.4× 70 0.8× 21 0.5× 14 268
Ziwen Yu China 3 197 1.5× 62 0.7× 110 1.2× 45 0.5× 32 0.7× 6 254
Shin Takesue Japan 6 138 1.1× 107 1.1× 60 0.6× 40 0.4× 58 1.3× 11 225
Xingang Bi China 9 61 0.5× 94 1.0× 48 0.5× 85 0.9× 31 0.7× 32 210

Countries citing papers authored by Mathieu Larroquette

Since Specialization
Citations

This map shows the geographic impact of Mathieu Larroquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Larroquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Larroquette more than expected).

Fields of papers citing papers by Mathieu Larroquette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Larroquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Larroquette. The network helps show where Mathieu Larroquette may publish in the future.

Co-authorship network of co-authors of Mathieu Larroquette

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Larroquette. A scholar is included among the top collaborators of Mathieu Larroquette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Larroquette. Mathieu Larroquette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Larroquette, Mathieu, et al.. (2024). How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers. 16(9). 1780–1780. 3 indexed citations
2.
3.
Carneiro, Fátima, Armelle Vinceneux, Mathieu Larroquette, et al.. (2024). Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d′Étude des Tumeurs Uro-Génitales) study. European Journal of Cancer. 199. 113534–113534. 2 indexed citations
4.
Daste, Amaury, et al.. (2023). Immunotherapy for Head and Neck Squamous Cell Carcinoma: Current Status and Perspectives. Immunotherapy. 16(3). 187–197. 12 indexed citations
5.
Reich, M., Juliane Berchoud, Myriam Jean‐Denis, et al.. (2023). 1971P Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study. Annals of Oncology. 34. S1053–S1053.
6.
Domblides, Charlotte, et al.. (2023). Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?. Cancers. 15(4). 1048–1048. 10 indexed citations
7.
Larroquette, Mathieu, Charlotte Domblides, Simon Lambert, et al.. (2023). Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice. Cancers. 15(23). 5558–5558. 5 indexed citations
8.
Larroquette, Mathieu, et al.. (2022). Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade. Cancers. 14(24). 6230–6230. 8 indexed citations
9.
Larroquette, Mathieu, Jean‐Philippe Guégan, Benjamin Besse, et al.. (2022). Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies. Journal for ImmunoTherapy of Cancer. 10(5). e003890–e003890. 105 indexed citations
10.
Larroquette, Mathieu, Charlotte Domblides, Amandine Quivy, et al.. (2021). Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review. European Journal of Cancer. 158. 47–62. 53 indexed citations
11.
Larroquette, Mathieu, Florent Peyraud, Charlotte Domblides, et al.. (2021). Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives. Cancer Treatment Reviews. 97. 102207–102207. 36 indexed citations
12.
Larroquette, Mathieu, Marine Gross‐Goupil, Amaury Daste, et al.. (2019). Which place for avelumab in the management of urothelial carcinoma?. Expert Opinion on Biological Therapy. 19(9). 863–870. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Avi Spira Breakdown of academic impact, for papers by Marco Moreira Breakdown of academic impact, for papers by Giulio Mandelli Breakdown of academic impact, for papers by Maxime Brunet Breakdown of academic impact, for papers by Robert A. Belderbos Breakdown of academic impact, for papers by Jiamin Chen Breakdown of academic impact, for papers by Emeline Vinatier Breakdown of academic impact, for papers by Ziwen Yu Breakdown of academic impact, for papers by Shin Takesue Breakdown of academic impact, for papers by Xingang Bi
Rankless by CCL
2026